Kevin Kabler focuses his practice on building and managing patent portfolios for life science-focused clients. He prepares and prosecutes domestic and international patent applications in a wide range of technical fields, including immuno-oncology, antibodies, personalized medicine, vaccines, biologics, RNAi, clean-tech, stem cells, immunotherapy, and small molecules. His practice also involves strategic patent counseling and due diligence in the life sciences, including evaluating risks from third-party patents and assisting in efforts to reduce identified risks.
Kevin counsels and partners with all types of life science companies and institutions at all stages of the business cycle. He also assists investors in assessing the competitive landscape, technology, and intellectual property assets and risks associated with target investments.
Kevin began his career at Fenwick & West as a patent agent in 2007. Prior to joining Fenwick & West, Kevin was a postdoctoral fellow in the laboratory of Nobel Laureate J. Michael Bishop at the University of California, San Francisco.
Kevin is a co-inventor on multiple patents and has published numerous scientific papers in leading peer-reviewed journals including Nature Medicine and Nature Biotechnology.